Paolo Fundaro, Director, 10% Owner at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,191,156 shares at $84.60 ($100.8M) on 2020-05-13, disclosed to the SEC on 2020-05-15.
Open-market sale of $100.8M ICPT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.60 | 595,578 | $50.4M | 50.0% |
| 2 | $84.60 | 595,578 | $50.4M | 50.0% |
| Total | $84.60 avg | 1,191,156 | $100.8M | 100% |
| Filing → |
| ICPT | SELL | 2015-07-24 | $166K | — | Filing → |
| ICPT | SELL | 2014-08-12 | $78K | — | Filing → |
| ICPT | SELL | 2014-05-09 | $75K | — | Filing → |